基本説明
Provides a systematic approach to the radiological evaluation and diagnosis. Includes new chapters on soft tissue lymphoma, soft tissue tumors in the pediatric patient, and biopsy of soft tissue tumors.
Full Description
This richly illustrated book provides a comprehensive survey of the growing role of medical imaging studies in the detection, staging, grading, tissue characterization, and post-treatment follow-up of soft tissue tumors. For each tumor group, imaging findings are correlated with clinical, epidemiologic, and histologic data. The relative merits and indications of various imaging modalities are discussed and compared. Particular emphasis is placed on MRI because of its unique contrast resolution and multiplanar imaging capabilities. This second, revised and updated edition includes new chapters on soft tissue lymphoma, soft tissue tumors in the pediatric patient and biopsy of soft tissue tumors. It aims to serve both as a systematic, descriptive textbook and as a rich pictorial database of soft tissue masses. This clinically oriented book will be of use not only to radiologists but also to orthopedic surgeons, oncologists and pathologists.
Contents
Imaging Modalities: Ultrasonography. Color Doppler Ultrasonography. Plain Radiography, Angiography and Computed Tomography. Nuclear Medicine Imaging. MR Imaging. Dynamic Contrast-Enhanced MR Imaging * Staging, Characterization and Grading: Staging. Grading and Characterization of Soft Tissue Tumors. General Imaging Strategy * Imaging of Soft Tissue Tumors: Tumors of Fibrous Tissue. Fibrohistiocytic Tumors. Lipomatous Tumors. Tumors and Tumorlike Lesions of Blood Vessels. Lymphatic Tumors. Tumors of Muscular Origin. Synovial Tumors. Tumors of Peripheral Nerves. Extraskeletal Cartilaginous and Osseous Tumors. Primitive Neuroectodermal Tumors and Related Lesions. Lesions of Uncertain Origin. Pseudotumoral Lesions. Soft Tissue Metastasis. Soft Tissue Lymphoma. Soft Tissue Tumors in the Pediatric Patient. Biopsy of Soft Tissue Tumors * Imaging after Treatment: Posttreatment Assessment of Soft Tissue Tumors.
